These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7807947)

  • 1. Biogenic amine metabolite patterns in the urine of monoamine oxidase A-deficient patients. A possible tool for diagnosis.
    Abeling NG; van Gennip AH; Overmars H; van Oost BA; Brunner HG
    J Inherit Metab Dis; 1994; 17(3):339-41. PubMed ID: 7807947
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoamine oxidase A deficiency: biogenic amine metabolites in random urine samples.
    Abeling NG; van Gennip AH; van Cruchten AG; Overmars H; Brunner HG
    J Neural Transm Suppl; 1998; 52():9-15. PubMed ID: 9564603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specification of the phenotype required for men with monoamine oxidase type A deficiency.
    Hebebrand J; Klug B
    Hum Genet; 1995 Sep; 96(3):372-6. PubMed ID: 7649563
    [No Abstract]   [Full Text] [Related]  

  • 4. Marked amine and amine metabolite changes in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase.
    Murphy DL; Sims KB; Karoum F; de la Chapelle A; Norio R; Sankila EM; Breakefield XO
    J Neurochem; 1990 Jan; 54(1):242-7. PubMed ID: 2293615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism.
    Brunner HG; Nelen MR; van Zandvoort P; Abeling NG; van Gennip AH; Wolters EC; Kuiper MA; Ropers HH; van Oost BA
    Am J Hum Genet; 1993 Jun; 52(6):1032-9. PubMed ID: 8503438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A.
    Brunner HG; Nelen M; Breakefield XO; Ropers HH; van Oost BA
    Science; 1993 Oct; 262(5133):578-80. PubMed ID: 8211186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase and behaviour.
    Brunner HG
    Ann Med; 1995 Aug; 27(4):431-2. PubMed ID: 8519502
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence found for a possible 'aggression gene'.
    Morell V
    Science; 1993 Jun; 260(5115):1722-3. PubMed ID: 8511575
    [No Abstract]   [Full Text] [Related]  

  • 9. Mild learning difficulties and offending behaviour--is there a link with monoamine oxidase A deficiency?
    Stamps VR; Abeling NG; van Gennip AH; van Cruchten AG; Gurling HM
    Psychiatr Genet; 2001 Sep; 11(3):173-6. PubMed ID: 11702062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic deficiencies of monoamine oxidase enzymes: a key to understanding the function of the enzymes in humans.
    Lenders JW; Brunner HG; Murphy DL; Eisenhofer G
    Adv Pharmacol; 1998; 42():297-301. PubMed ID: 9327899
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of monoamine oxidase inhibitors in chronic neurodegeneration.
    Riederer P; Müller T
    Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):233-240. PubMed ID: 27998194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of some biological trait markers in migraine: deuterated tyramine challenge test, monoamine oxidase, phenolsulfotransferase and plasma and urinary biogenic amine and acid metabolite levels.
    Davis BA; Dawson B; Boulton AA; Yu PH; Durden DA
    Headache; 1987 Jul; 27(7):384-9. PubMed ID: 3477534
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary acid metabolites of biogenic amines in schizophrenic patients.
    Domino EF
    Schizophr Bull; 1980; 6(2):238-44. PubMed ID: 6154967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into Brunner syndrome and potential for targeted therapy.
    Palmer EE; Leffler M; Rogers C; Shaw M; Carroll R; Earl J; Cheung NW; Champion B; Hu H; Haas SA; Kalscheuer VM; Gecz J; Field M
    Clin Genet; 2016 Jan; 89(1):120-7. PubMed ID: 25807999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linkage analysis of the monoamine A and B genes using newly-defined polymorphisms.
    Harris BD; Kurth JH; Barnes RI; Bowcock AM; Kurth MC
    Cytogenet Cell Genet; 1993; 62(4):236-7. PubMed ID: 8440143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes.
    Lenders JW; Eisenhofer G; Abeling NG; Berger W; Murphy DL; Konings CH; Wagemakers LM; Kopin IJ; Karoum F; van Gennip AH; Brunner HG
    J Clin Invest; 1996 Feb; 97(4):1010-9. PubMed ID: 8613523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine oxidase deficiency in males with an X chromosome deletion.
    Sims KB; de la Chapelle A; Norio R; Sankila EM; Hsu YP; Rinehart WB; Corey TJ; Ozelius L; Powell JF; Bruns G
    Neuron; 1989 Jan; 2(1):1069-76. PubMed ID: 2483108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, biochemical, and neuropsychiatric evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes.
    Collins FA; Murphy DL; Reiss AL; Sims KB; Lewis JG; Freund L; Karoum F; Zhu D; Maumenee IH; Antonarakis SE
    Am J Med Genet; 1992 Jan; 42(1):127-34. PubMed ID: 1308352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Formation of the superoxide anion radical during the oxidation of biogenic amines catalyzed by mitochondrial monoamine oxidase].
    Volkovitskaia OE; Bochev PG; Ribarev SR; Gorkin VZ; Kagan VE
    Biull Eksp Biol Med; 1986 Dec; 102(12):687-9. PubMed ID: 3026510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.